Cargando…

Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study

Detalles Bibliográficos
Autores principales: Zheng, Guanhao, Zhang, Jianxin, Wang, Bei, Cai, Jiaqi, Wang, Lili, Hou, Kaixuan, Zhang, Yan, Zhang, Liang, Yang, Zhitao, He, Juan, Bian, Xiaolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960481/
https://www.ncbi.nlm.nih.gov/pubmed/35226348
http://dx.doi.org/10.1007/s40121-021-00569-6
_version_ 1784677390274789376
author Zheng, Guanhao
Zhang, Jianxin
Wang, Bei
Cai, Jiaqi
Wang, Lili
Hou, Kaixuan
Zhang, Yan
Zhang, Liang
Yang, Zhitao
He, Juan
Bian, Xiaolan
author_facet Zheng, Guanhao
Zhang, Jianxin
Wang, Bei
Cai, Jiaqi
Wang, Lili
Hou, Kaixuan
Zhang, Yan
Zhang, Liang
Yang, Zhitao
He, Juan
Bian, Xiaolan
author_sort Zheng, Guanhao
collection PubMed
description
format Online
Article
Text
id pubmed-8960481
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-89604812022-04-12 Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study Zheng, Guanhao Zhang, Jianxin Wang, Bei Cai, Jiaqi Wang, Lili Hou, Kaixuan Zhang, Yan Zhang, Liang Yang, Zhitao He, Juan Bian, Xiaolan Infect Dis Ther Correction Springer Healthcare 2022-02-28 2022-04 /pmc/articles/PMC8960481/ /pubmed/35226348 http://dx.doi.org/10.1007/s40121-021-00569-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Zheng, Guanhao
Zhang, Jianxin
Wang, Bei
Cai, Jiaqi
Wang, Lili
Hou, Kaixuan
Zhang, Yan
Zhang, Liang
Yang, Zhitao
He, Juan
Bian, Xiaolan
Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
title Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
title_full Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
title_fullStr Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
title_full_unstemmed Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
title_short Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
title_sort correction to: ceftazidime-avibactam in combination with in vitro non-susceptible antimicrobials versus ceftazidime-avibactam in monotherapy in critically ill patients with carbapenem-resistant klebsiella pneumoniae infection: a retrospective cohort study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960481/
https://www.ncbi.nlm.nih.gov/pubmed/35226348
http://dx.doi.org/10.1007/s40121-021-00569-6
work_keys_str_mv AT zhengguanhao correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT zhangjianxin correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT wangbei correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT caijiaqi correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT wanglili correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT houkaixuan correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT zhangyan correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT zhangliang correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT yangzhitao correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT hejuan correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy
AT bianxiaolan correctiontoceftazidimeavibactamincombinationwithinvitrononsusceptibleantimicrobialsversusceftazidimeavibactaminmonotherapyincriticallyillpatientswithcarbapenemresistantklebsiellapneumoniaeinfectionaretrospectivecohortstudy